RNAC Operating Cash Flow (Statement)
Cartesian Therapeutics Inc · Operating Cash Flow (Statement)
RNAC Operating Cash Flow (Statement)
Latest reported-$76.07Mperiod ending
RNAC Cash from Operations (-$12.69M → -$76.07M)
Annual operating cash flow (statement)
High-resolution chart · PNG
RNAC operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -73,941,000 | |
| -23,674,000 | |
| -51,161,000 | |
| -31,631,000 | |
| -60,382,000 | |
| 34,881,000 | |
| -51,435,000 | |
| -59,161,000 | |
| -52,037,000 | |
| -19,683,000 | |
| -22,463,000 | |
| -12,686,000 |